Clinical Trial Update: Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing nab-paclitaxel with solvent-based taxanes as first-line therapy for advanced ovarian cancer is currently recruiting, including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• Solvent-based taxanes (paclitaxel and/or docetaxel)

Snippet

Sponsor: Women's Hospital School Of Medicine Zhejiang University | Conditions: Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV | Phase 3 | Status: RECRUITING